Biodesix, Inc. Common Stock vs. Caris Life Sciences, Inc. Common Stock
BDSX
Biodesix, Inc. Common Stock
$8.53 -57.01%
VS CAICaris Life Sciences, Inc. Common Stock
$26.03 -21.64%
Caris Life Sciences, Inc. Common Stock (CAI) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BDSX | CAI | |
|---|---|---|
| Market Cap | $209.33 million | $7.47 billion |
CAI leads on 1 of 1 size & scale factors.
Dividend
| BDSX | CAI | |
|---|---|---|
| Dividend Yield | — | 4.61% |
BDSX and CAI split the dividend factors evenly.
Risk & Sentiment
| BDSX | CAI | |
|---|---|---|
| Short Interest | 0.51% | 0.13% |
CAI leads on 1 of 1 risk & sentiment factors.
Dig deeper: BDSX overview, BDSX financials, CAI overview, CAI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.